Mini Case Chapter 13

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

1.

What were the impacts on Novo as a result of operating in a segmented


market?
In particular, the lack of availability and high cost of equity capital in Denmark
resulted in Nova having a higher cost of capital than its main multinational
competitors. Furthermore, the company have to faced additional barriers imposed by
the government of Denmark on securities issuances, the regulation in Denmark were
not designed so that firm could issue shares at market value. As a result, this will
prevent Novo from fully exploiting its competitive advantage in research on insulin
and industrial enzymes.Its revised weighted average cost of capital should have
become a new reference hurdle rate when evaluating new capital investments in
Denmark or abroad

2. What were the primary causes of the market segmentation?


Six characteristics of Danish equity market were responsible for market
segmentation:
1) Asymmetric information base of Danish and foreign investors;
2) Taxation: capital gain on stock over 2 years were taxed at 50% and less than 2
years is 75%
3) Alternative sets of feasible portfolios: danish government policy prevent the
company from choosing the securities as well as provide a high rate of return on
government bond
4) Financial risk: financial leverage utilized by Danish firm was very high
5) Foreign exchange risk:
6) Political risk : the foreign investors avoid the Danish market and thus this market
became segmented
3. Ultimately, what actions did novo take to escape its segmented market?
● Novo increased the level of its financial and technical disclosure in both
Danish and English versions. Novo listed its shares on the London Stock
Exchange to facilitate conversion and to gain visibility. These twin actions
were the key to dissolving the information barrier and, of course, they also
raised a large amount of long-term capital on favorable terms, which would
have been unavailable in Denmark.
● Novo organized a seminar in New York City on April 30, 1980. Soon after the
seminar a few sophisticated individual U.S. investors began buying Novo’s
shares and convertibles through the London Stock Exchange.
● During the first half of 1981, under the guidance of Goldman Sachs and with
the assistance of Morgan Grenfell and Copenhagen Handelsbank, Novo
eventually listed on the New York Stock Exchange.

You might also like